secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001628280-26-032164
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical Q1 2026: Net sales $759.9M (+27% YoY); raises FY non-GAAP EPS guidance to $4.70-$4.80
--------------------------------------------------------------------------------

- GAAP diluted EPS $0.90 (+66.6% YoY); non-GAAP diluted EPS $1.12 (+64.7% YoY).
- Worldwide net sales $759.9M, up 27% as-reported; base business (ex-Nevro) up 13.2%.
- FY2026 revenue guidance reaffirmed at $3.18B–$3.22B; non-GAAP EPS guidance raised to $4.70–$4.80 from $4.40–$4.50.
- U.S. net sales +25% YoY; international +35.6% as-reported (+27.8% constant currency).
- Operating margin expanded on manufacturing initiatives and operating leverage.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000162828026032164/0001628280-26-032164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000162828026032164/gmed-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-032164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer